Page 9 - 2019_04-Haematologica-web

haematologica Journal of the Ferrata Storti Foundation
e131 A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM)
Lionel Ades et al.
http://www.haematologica.org/content/104/4e131
e134 Positive impact of molecular analysis on prognostic scores in essential thrombocythemia: a single center prospective cohort experience Damien Luque Paz et al.
http://www.haematologica.org/content/104/4/e134
e138 Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated mod- els of acute myeloid leukemia
Michael R. McKeown et al. http://www.haematologica.org/content/104/4/e138
e143 Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms
Anna B. Halpern et al.
http://www.haematologica.org/content/104/4/e143
e147 Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900
Hugo F. Fernandez et al. http://www.haematologica.org/content/104/4/e147
e151 Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study
Anton Hagenbeek et al.
http://www.haematologica.org/content/104/4/e151
e154 Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL2 rearrangements
Solène M. Evrard et al.
http://www.haematologica.org/content/104/4/e154
e158 DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers
Arantza Onaindia et al. http://www.haematologica.org/content/104/4/e158
e163 Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma Anita Kumar et al,
http://www.haematologica.org/content/104/4/e163
Case Reports
Case Reports are available online only at www.haematologica.org/content/104/4.toc
e167 Recognition of hemophagocytic lymphohistiocytosis in sickle cell vaso-occlusive crises is a potentially lifesaving diagnosis Orly Leiva et al.
http://www.haematologica.org/content/104/4/e167
e170 Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia Ramzi Abboud et al.
http://www.haematologica.org/content/104/4/e170
e174 Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant Shamzah Araf et al.
http://www.haematologica.org/content/104/4/e174
Comments
Comments are available online only at www.haematologica.org/content/104/4.toc
e178 Comment to “The outcome of peripheral T-cell lymphoma patients failing first-line therapy” Peter Dreger
http://www.haematologica.org/content/104/4/e178
e179 The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell Project Monica Bellei and Massimo Federico
http://www.haematologica.org/content/104/4/e179
Haematologica 2019; vol. 104 no. 4 - April 2019 http://www.haematologica.org/